Glidian, Inc.

Glidian is a healthcare technology company dedicated to optimizing prior authorization processes, enhancing efficiency for healthcare providers through advanced digital solutions. Glidian, founded in 2016, specializes in simplifying the healthcare authorization process. The company's operations have remained focused on this core service since inception, based in Redwood City, US. Glidian was founded by individuals with prior experience in technology and healthcare.

The company has engaged in one deal as of March 17, 2025. Glidian specializes in providing advanced solutions for the healthcare authorization process, specifically focusing on simplifying prior authorizations. Their core offerings include a digital platform that streamlines the workflow for healthcare providers, enabling them to efficiently manage authorizations with payors across various states. The platform is designed to alleviate administrative burdens, improving the speed and accuracy of authorization submissions and communication with insurance companies.

Glidian serves a diverse client base that includes thousands of healthcare providers, ranging from small practices to larger hospital systems, all seeking to enhance operational efficiency and patient care. The company’s solutions are available across all 50 states, catering to a wide geographical market and addressing critical pain points in the healthcare authorization landscape. Glidian operates on a subscription-based revenue model, providing its services primarily through partnerships with healthcare providers and institutions. Clients typically engage with Glidian by subscribing to its platform, which offers tiered pricing plans based on the level of service and features required.

The transactions facilitate seamless access to the digital tools necessary for managing prior authorizations, allowing providers to optimize their workflows. The company’s flagship offerings include its proprietary software that integrates with existing healthcare systems, ensuring that providers can swiftly navigate the complexities of insurance authorizations. Although specific pricing details are not disclosed, the subscription model positions Glidian for consistent revenue generation as healthcare providers increasingly rely on their services to enhance operational efficiency. In March 2025, Infinx Services Private Limited, a portfolio company of Norwest Venture Partners and KKR, acquired Glidian.

This acquisition will enable Glidian to enhance its AI-driven revenue cycle management capabilities and expand its reach in the laboratory market. The focus will be on designing new products that leverage AI technology to further streamline healthcare processes, with anticipated launches in late 2025. Additionally, Glidian plans to explore expansion into new geographic regions, targeting international markets in Europe and Asia by 2026.